Developing symptom lists for people with cancer treated with targeted therapies
AuthorsSodergren, S. C.
Wheelwright, S. J.
Darlington, A. S.
Arraras, J. I.
Leahy, Michael G
Rohde, G. E.
Johnson, C. D.
AffiliationSchool of Health Sciences, University of Southampton, Southampton, UK.
MetadataShow full item record
AbstractBackground: Targeted therapies (TTs) have revolutionised cancer treatment with their enhanced specificity of action. Compared with conventional therapies, TTs are delivered over a longer period and often have unusual symptom profiles. Patient-reported outcome measures such as symptom side-effect lists need to be developed in a time-efficient manner to enable a rapid and full evaluation of new treatments and effective clinical management OBJECTIVE: The aim of this study was to develop a set of TT-related symptoms and identify the optimal method for developing symptom lists. Patients and methods: Symptoms from TT treatment in the context of Chronic Myeloid Leukaemia (CML), HER2-positive breast cancer, or Gastrointestinal Stromal Tumours (GIST) were identified through literature reviews, interviews with healthcare professionals (HCPs) and patients, and patient focus groups. The symptom set was then pilot tested in patients across the three cancer diagnoses: The number of items derived from each source (literature, patients, or HCPs) were compared. Results: A total of 316 patients and 86 HCPs from 16 countries participated. An initial set of 209 symptoms was reduced to 61 covering 12 symptom categories. Patient interviews made the greatest contribution to the item set. Conclusions: Symptom lists should be created based on input from patients. The item set described will be applicable to the assessment of new TTs, and in monitoring treatment.
CitationSodergren SC, Wheelwright SJ, Fitzsimmons D, Efficace F, Sprangers M, Fayers P, et al. Developing Symptom Lists for People with Cancer Treated with Targeted Therapies. Target Oncol. 2020.
- The future of Cochrane Neonatal.
- Authors: Soll RF, Ovelman C, McGuire W
- Issue date: 2020 Nov
- Psychometric properties of self-report concussion scales and checklists.
- Authors: McLeod TC, Leach C
- Issue date: 2012 Mar-Apr
- Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
- Authors: Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R, White P
- Issue date: 2020 Sep
- Development, psychometric evaluation, and initial feasibility assessment of a symptom tracker for use by patients with heart failure (HFaST).
- Authors: Lewis EF, Coles TM, Lewis S, Nelson LM, Barrett A, Romano CD, Stull DE, Turner SJ, Chang CG
- Issue date: 2019 May 2
- Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group.
- Authors: Sodergren SC, Copson E, White A, Efficace F, Sprangers M, Fitzsimmons D, Bottomley A, Johnson CD
- Issue date: 2016 Jun